European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,405. ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The company’s shares opened today at p1,392.50. According ...

Get Our Latest Stock Report on GSK GSK Stock Up 0.8 % GSK opened at $35.35 on Friday. GSK plc has a 1-year low of $31.72 and a 1-year high of $45.92. The firm’s 50 day simple moving average is ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

mapping gene expression to particular locations in the brain to try to identify and validate new drug targets for the neurodegenerative disorder. GSK is paying out €33.5 million in cash to get ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

Blackstone (BX.N), opens new tab is in talks to buy a sizeable stake in a New York City 50-story office building from institutional investors of JPMorgan Asset Management, two sources familiar ...

After hours: February 3 at 6:25:46 p.m. EST ...